Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis

Journal of Infectious Diseases

Volumn 182, Issue 2, 2000, Pages 545-550

  LeMonte, A M ^a,c   Washum, K E ^a   Smedema, M L ^a,c   Schnizlein Bick, C ^a   Kohler, S M ^b,c   Wheat, L J ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Histoplasmosis Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ANTAGONISM; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HISTOPLASMOSIS; ITRACONAZOLE; MICE; MICROBIAL SENSITIVITY TESTS;

EID: 0033845179     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315717     Document Type: Article

References (29)

1. Histoplasmosis in the acquired immunodeficiency syndrome
2. Histoplasma capsulatum infections of the central nervous system: A clinical review
3. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis
4. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome
5. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis
6. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome
7. Fluconazole therapy for coccidioidal meningitis
8. AIDS Clinical Trial Group: Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome
9. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome
10. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum
11. Histoplasmosis: Experience during outbreaks in Indianapolis and review of the literature
12. Current and emerging azole antifungal agents
13. Use of amphotericin B with azole antifungal drugs: What are we doing?
14. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice
15. Antifungal susceptibility testing on isolates of Histoplasma capsulatum obtained from a clinical trial evaluating fluconazole treatment in patients with AIDS
16. Evaluation of the activity of three antifungal agents against the yeast form of patient isolates of Histoplasma capsulatum as determined by macrobroth in vitro susceptibility testing
17. In vitro evaluation of combination of fluconazole and flucytesine against Cryptococcus neoformans var. neoformans
18. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen
19. Rank transformations as a bridge between parametric and nonparametric statistics
20. A pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host
21. Chronic progressive CNS histoplasmosis presenting in childhood: Response to fluconazole therapy
22. Chronic Histoplasma capsulatum infection of the central nervous system successfully treated with fluconazole
23. Central nervous system histoplasmosis mimicking a brain tumor: Difficulties in diagnosis and treatment
24. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome
25. Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial
26. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis
27. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models
28. A multicenter randomized trial comparing amphotericin B (AmB) and liposomal amphotericin B (AmBisome, LAmB) as induction therapy of disseminated histoplasmosis (DH) in AIDS patients
29. Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity